David Penson Archives
Aug. 4, 2022—Vanderbilt's REACH for Survivorship Clinic takes a holistic approach to help treat prostate cancer patients.
Apr. 14, 2021—H. Rodes Hart, BA’54, and Patricia Ingram Hart, BA’57, whose generous gifts continue to advance the mission of Vanderbilt as one of the world’s great universities for learning and discovery, have endowed a second chair in Urologic Surgery.
Mar. 28, 2019—Prostate cancer patients in Nashville and Los Angeles are benefiting from a computer-based decision aid that implements the latest study results to tailor treatment options to an individual’s quality-of-life priorities.
Mar. 28, 2019—The Terry Burke Fund for Bladder Cancer Research at Vanderbilt-Ingram Cancer Center is supporting a range of discovery research aimed at improving outcomes for bladder cancer patients, and it is helping train the next generation of bladder cancer physician-scientists.
Apr. 5, 2018—Beginning July 1, Vanderbilt University Medical Center’s Department of Urologic Surgery, which is currently housed within the Medical Center’s Section of Surgical Sciences, will become an independent department.
Sep. 7, 2017—David Penson, M.D., MPH, Paul V. Hamilton, M.D., and Virginia E. Howd Professor of Urologic Oncology and chair of the Department of Urologic Surgery, has been named an associate editor for The Journal of the National Cancer Institute (JNCI).
May. 19, 2017—In 2012, the United States Preventive Services Task Force recommended that men of all ages should not be routinely screened for levels of prostate-specific antigen (PSA). That group now recommends that men ages 55 to 69 should talk with their doctors and make well-informed individual decisions about the potential harms and benefits of PSA screening, and treatment if cancer is found.
Apr. 24, 2017—In 2012, the United States Preventive Services Task Force recommended that men of all ages should not be routinely screened for levels of prostate-specific antigen (PSA). These are the blood tests to detect the possibility of prostate cancer.
Apr. 20, 2017—A federal task force has changed its recommendation about prostate cancer screening for some older men. The United States Preventive Services Task Force (USPSTF) now recommends that men between the ages of 55 to 69 consult with their physicians about getting routine screening blood tests to detect prostate cancer.
Mar. 30, 2017—David Penson, M.D., MPH, Paul V. Hamilton, M.D., and Virginia E. Howd Professor of Urologic Oncology and chair of the Department of Urologic Surgery, has been selected to chair the American Urological Association (AUA) Science & Quality Council, according to an announcement from the AUA Board of Directors.
Mar. 21, 2017—Faced with the negative quality-of-life effects from surgery and radiation treatments for prostate cancer, low risk patients may instead want to consider active surveillance with their physician, according to a study released Tuesday by the Journal of the American Medical Association (JAMA).
Sep. 22, 2016—Vanderbilt University Medical Center is the world’s first site to treat a patient in the TULSA-PRO Ablation Clinical Trial (TACT), which employs an emerging therapy that uses MRI guidance and robotically driven therapeutic ultrasound to obtain precise prostate cancer tissue ablation.